Philadelphia Dentist Taking a Major Initiative to Train and Educate Healthcare

Professionals to Address the Prescription Problem of Abuse and Drug Addiction

Dentists to Fight Opioid Epidemic

Philadelphia, PA, October 17, 2018 --(PR.com)-- With opioid abuse reaching epidemic proportions, Dr.
Mansoor Madani, director of Bala Institute of Oral Surgery, is educating doctors, healthcare professional
and prescribers on this national crisis. “For change to happen, it needs to start with the prescribers,” says
Dr. Mansoor Madani, who has been giving continuing education courses to dental and medical
professionals for the past twenty years.

It is estimated that over 115 people die in the U.S. from opioid overdose and the number is increasing. In
2017, over 72,000 died from drug overdose in the U.S. more than car crashes, breast cancer and gun
violence. In 2017, 5,443 people died of drug overdose in Pennsylvania, that's 15 individuals each day.
From 2000 to 2017, more than half a million people died from drug overdose. 250 million prescriptions
are written every year for opioids, that is one bottle of opioids for every adult in the U.S. 75% of opioid
addiction starts with patients receiving prescriptions from their doctors. “With some exceptions, most
healthcare providers have received minimal training in how to recognize substance abuse in their
patients,” according to Dr. Mansoor Madani. “Most medical and dental schools do not provide in-depth
training on substance abuse; often, substance abuse education is limited to classroom or clinical
electives,” adds Madani. After graduation, most of these professionals receive very limited training on
treating pain.

Until now, most doctors receiving their DEA licenses were not required to have additional training on a
regular basis. “As prescribers, we all have a role to play in reducing prescrip-tion drug misuse and abuse.
This requires continuing education and training on how to manage pain, when it is appropriate to give
narcotics, how much and how often,” says Dr. Madani, who is also an associate professor of Oral and
Maxillofacial Surgery at Temple University in Philadelphia and has organized and taught multiple
comprehensive continuing education state mandatory training courses in “pain management and drug
addiction.” A crucial step in tackling the problem of prescription drug abuse is to raise awareness through
the education of parents, youth, patients and healthcare providers.

“We are taking a major initiative to review the history of opioid treatment and the problem of prescription
abuse and drug addiction. We hope to have a meaningful impact on educating healthcare professionals of
this unfortunate epidemic that kills almost 4 individual every hour in the U.S.,” says Madani. He will
present a comprehensive state mandatory course at the Philadelphia College of Osteopathic Medicine on
October 20, 2018 (8:00 AM-12:30 PM) on Pain Management, Drug Addiction and Practice of Prescribing
and Dispensing Opioids. If you would like to speak to Dr. Madani about this in more detail - especially
about the lack of education the doctors are receiving on this crisis, there is an abundant amount of
feedback he can provide. Bala Institute of Oral Surgery invites you to join. They have over 300 healthcare
professionals registered for this course. More details can be found on the website: www.balasurgery.com.

Note: Act 124, effective January 1, 2017 - Pennsylvania licensing boards require dispensers and

Page 1/3
PR.com Press Release Distribution Terms of Use
prescribers who are applying for the renewal of a license to complete at least two hours of continuing
education in pain management, identification of addiction or the practice of prescribing or dispensing
opioids.

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
Bala Institute of Oral Surgery
Mansoor Madani
610-496-0811
Contact via Email
www.balasurgery.com
DrMMadani@gmail.com
610-667-6161

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/767586

Page 3/3
PR.com Press Release Distribution Terms of Use